Skip to main content
. 2015 May 27;6(22):18875–18890. doi: 10.18632/oncotarget.4303

Figure 7. Tumor growth.

Figure 7

A. and animal survival B. of HSJD-ES-004 and HSJD-ES-006 PDX models upon single-agent and combination therapies. Olaparib and Trabectedin in combination induced complete tumor regression A. and improved overall survival B. in both PDX models as compared with single treatments and controls.